No products in the cart.
European stocks posted their fifth straight weekly advance as investors remained confident about artificial intelligence demand. Novo Nordisk A/S jumped 6.5% after the UK regulator approved a higher dose of its obesity drug.
European stocks posted their fifth straight weekly advance as investors remained confident about artificial intelligence demand. Novo Nordisk A/S jumped 6.5% after the UK regulator approved a higher dose of its obesity drug.